跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML - PPB Drug Approval Details
Approvals
/
PPB
/
SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML
Approved
STANDARD
SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML
SANOFI HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
9e2df0b0e1ba4d35
Company
SANOFI HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
9e2df0b0e1ba4d35
Product Name
SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML
Drug Hk Name
SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML
Registration Code
HK-67289
Company Name
SANOFI HONG KONG LIMITED
Company Detail Path
/organization/sanofi-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2021-12-15
Company Address
1/F & SECTION 212 ON 2/F, AXA SOUTHSIDE, 38, WONG CHUK HANG ROAD, WONG CHUK HANG, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
9e2df0b0e1ba4d35
Type
Standard
Back to PPB Approvals